Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference37 articles.
1. Abiraterone in metastatic prostate cancer without previous chemotherapy.;Ryan;N Engl J Med,2013
2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.;Tannock;N Engl J Med,2004
3. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.;Petrylak;N Engl J Med,2004
4. Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.;Scher;J Clin Oncol,2011
5. Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.;Kelly;J Clin Oncol,2012
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Semisynthesis of anthocyanins;Semisynthesis of Bioactive Compounds and their Biological Activities;2024
2. Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy;BMC Cancer;2020-06-18
3. Effects of Black Raspberries and Their Ellagic Acid and Anthocyanin Constituents on Taxane Chemotherapy of Castration-Resistant Prostate Cancer Cells;Scientific Reports;2019-03-13
4. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration‐resistant prostate cancer;The Prostate;2018-10-21
5. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer;Oncogene;2017-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3